Literature DB >> 19368979

Chronic obstructive pulmonary disease--an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease.

Kei Nishiyama1, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Natsuhiko Ehara, Ryouji Taniguchi, Neiko Ozasa, Naritatsu Saito, Kozo Hoshino, Masanao Touma, Toshihiro Tamura, Yoshisumi Haruna, Satoshi Shizuta, Takahiro Doi, Masanori Fukushima, Toru Kita, Takeshi Kimura.   

Abstract

BACKGROUND: Limited data are available on long-term mortality and morbidity of patients with chronic obstructive pulmonary disease (COPD) and ischemic heart disease. We examined how COPD affects long-term mortality and morbidity after undergoing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
METHODS: We analyzed 9877 consecutive patients who underwent their first elective PCI (n=6878) and CABG (n=2999) in 2000-2002 at 30 institutions listed in the CREDO-Kyoto registry.
RESULTS: COPD was diagnosed in 240 patients (2.4%). In-hospital mortality (1.3% vs. 1.2%, p=0.972) did not differ between patients with and without COPD. During long-term follow-up (42. 8 month s), 906 patients (9.4%) died, 517 (5.3%) of whom died of cardiovascular death and 376 (3.9%), of cardiac death. At 3 years, the unadjusted survival rate and the rates of freedom from cardiovascular death and cardiac death were 92.1%, 95.3%, and 96.5% in the total population and 82.8%, 91.7%, and 92.1% in patients with COPD respectively. Log-rank test indicated that COPD was associated with higher incidence of all-cause mortality (p<0.0001), cardiovascular death (p=0.0002), and cardiac death (p<0.0001). Multivariate analyses indicated that COPD was an independent predictor of all-cause mortality (hazard ratio 1.36, p=0.0003), cardiovascular death (hazard ratio 1.28, p=0.0407), and cardiac death (hazard ratio 1.48, p=0.003).
CONCLUSIONS: COPD is an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19368979     DOI: 10.1016/j.ijcard.2009.02.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Long-Term Outcomes for Chinese COPD Patients After PCI: A Propensity Score Matched, Double-Cohort Study.

Authors:  Yitian Zheng; Yu Qi; Samuel Seery; Wenyao Wang; Wei Zhao; Tao Shen; Lequn Zhou; Jie Yang; Chen Li; Xuliang Wang; Jun Gao; Xiangbin Meng; Erdan Dong; Yi-Da Tang
Journal:  Front Cardiovasc Med       Date:  2022-06-09

2.  Long-term mortality in patients with chronic obstructive pulmonary disease following extracorporeal membrane oxygenation for cardiac assist after cardiovascular surgery.

Authors:  Klaus Distelmaier; Alexander Niessner; Dominik Haider; Irene M Lang; Gottfried Heinz; Gerald Maurer; Herbert Koinig; Barbara Steinlechner; Georg Goliasch
Journal:  Intensive Care Med       Date:  2013-04-24       Impact factor: 17.440

3.  Coronary artery disease is under-diagnosed and under-treated in advanced lung disease.

Authors:  Robert M Reed; Michael Eberlein; Reda E Girgis; Salman Hashmi; Aldo Iacono; Steven Jones; Giora Netzer; Steven Scharf
Journal:  Am J Med       Date:  2012-09-06       Impact factor: 4.965

4.  Extracellular vesicles enclosed-miR-421 suppresses air pollution (PM2.5 )-induced cardiac dysfunction via ACE2 signalling.

Authors:  Hongyun Wang; Tianhui Wang; Wei Rui; Jinxin Xie; Yuling Xie; Xiao Zhang; Longfei Guan; Guoping Li; Zhiyong Lei; Raymond M Schiffelers; Joost P G Sluijter; Junjie Xiao
Journal:  J Extracell Vesicles       Date:  2022-05

5.  Outcomes in Patients With Severe Chronic Lung Disease Undergoing Index Cardiac Operations.

Authors:  Lauren V Huckaby; Edgar Aranda-Michel; Ibrahim Sultan; Danny Chu; Shangzhen Chen; Floyd Thoma; Arman Kilic
Journal:  Ann Thorac Surg       Date:  2020-12-02       Impact factor: 5.102

6.  Pleural subxyphoid drain confers better pulmonary function and clinical outcomes in chronic obstructive pulmonary disease after off-pump coronary artery bypass grafting: a randomized controlled trial.

Authors:  Solange Guizilini; Marcela Viceconte; Gabriel Tavares da M Esperança; Douglas W Bolzan; Milena Vidotto; Rita Simone L Moreira; Andréia Azevedo Câncio; Walter J Gomes
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

7.  Hypothesis of Long-Term Outcome after Coronary Revascularization in Japanese Patients Compared to Multiethnic Groups in the US.

Authors:  Taku Inohara; Shun Kohsaka; Masashi Goto; Yutaka Furukawa; Masanori Fukushima; Ryuzo Sakata; MacArthur Elayda; James M Wilson; Takeshi Kimura
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 8.  Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Chakshu Gupta; Guang Ma Xu
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

9.  The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease.

Authors:  Sinem Özyılmaz; Mehmet Fethi Alışır; Osman Akın Serdar; Esra Uzaslan
Journal:  Anatol J Cardiol       Date:  2015-07-20       Impact factor: 1.596

10.  Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions.

Authors:  Rafał Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Dariusz Dudek; Stanisław Bartuś
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.